These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35075790)

  • 1. Behavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder.
    Waldron S; Pass R; Griesius S; Mellor JR; Robinson ESJ; Thomas KL; Wilkinson LS; Humby T; Hall J; Dwyer DM
    Genes Brain Behav; 2022 Apr; 21(4):e12797. PubMed ID: 35075790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mild impairment in reversal learning in a bowl-digging substrate deterministic task but not other cognitive tests in the Dlg2+/- rat model of genetic risk for psychiatric disorder.
    Griesius S; Waldron S; Kamenish KA; Cherbanich N; Wilkinson LS; Thomas KL; Hall J; Mellor JR; Dwyer DM; Robinson ESJ
    Genes Brain Behav; 2023 Dec; 22(6):e12865. PubMed ID: 37705179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2.
    Pass R; Haan N; Humby T; Wilkinson LS; Hall J; Thomas KL
    Genes Brain Behav; 2022 Apr; 21(4):e12799. PubMed ID: 35118804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DLG2 deficiency in mice leads to reduced sociability and increased repetitive behavior accompanied by aberrant synaptic transmission in the dorsal striatum.
    Yoo T; Kim SG; Yang SH; Kim H; Kim E; Kim SY
    Mol Autism; 2020 Mar; 11(1):19. PubMed ID: 32164788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity.
    Griesius S; O'Donnell C; Waldron S; Thomas KL; Dwyer DM; Wilkinson LS; Hall J; Robinson ESJ; Mellor JR
    Neuropsychopharmacology; 2022 Jun; 47(7):1367-1378. PubMed ID: 35115661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel promoters and coding first exons in DLG2 linked to developmental disorders and intellectual disability.
    Reggiani C; Coppens S; Sekhara T; Dimov I; Pichon B; Lufin N; Addor MC; Belligni EF; Digilio MC; Faletra F; Ferrero GB; Gerard M; Isidor B; Joss S; Niel-Bütschi F; Perrone MD; Petit F; Renieri A; Romana S; Topa A; Vermeesch JR; Lenaerts T; Casimir G; Abramowicz M; Bontempi G; Vilain C; Deconinck N; Smits G
    Genome Med; 2017 Jul; 9(1):67. PubMed ID: 28724449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphism.
    Chen Y; Karaca E; Robin NH; Goodloe D; Al-Beshri A; Dean SJ; Hurst ACE; Carroll AJ; Mikhail FM
    Genet Med; 2024 Jan; 26(1):101010. PubMed ID: 37860969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel Dlg2 isoform differentially expressed in IFNβ-producing plasmacytoid dendritic cells.
    Ali S; Hoven A; Dress RJ; Schaal H; Alferink J; Scheu S
    BMC Genomics; 2018 Mar; 19(1):194. PubMed ID: 29703139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans Retinoic Acid-induced Abnormal Hippocampal Expression of Synaptic Genes
    Qin XY; Fang H; Shan QH; Qi CC; Zhou JN
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Deficiency of the Psychiatric Risk Gene DLG2/PSD-93 Causes Excitatory Synaptic Deficits in the Dorsolateral Striatum.
    Yoo T; Joshi S; Prajapati S; Cho YS; Kim J; Park PH; Bae YC; Kim E; Kim SY
    Front Mol Neurosci; 2022; 15():938590. PubMed ID: 35966008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.
    Shao YW; Wood GA; Lu J; Tang QL; Liu J; Molyneux S; Chen Y; Fang H; Adissu H; McKee T; Waterhouse P; Khokha R
    Oncogene; 2019 Jan; 38(2):291-298. PubMed ID: 30093633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.
    Grayson B; Barnes SA; Markou A; Piercy C; Podda G; Neill JC
    Curr Top Behav Neurosci; 2016; 29():403-428. PubMed ID: 26510740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
    Zhuang RJ; Bai XX; Liu W
    Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
    Li S; Yan G; Liu W; Li C; Wang X
    Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.
    Thomson S; Dyck B; Daya R; Ho J; Bernardo A; Tian Y; Mishra RK
    Synapse; 2019 May; 73(5):e22084. PubMed ID: 30582667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system - implications for the 3Rs and preclinical drug discovery.
    Mitchell EJ; Brett RR; Armstrong JD; Sillito RR; Pratt JA
    J Psychopharmacol; 2020 Jul; 34(7):709-715. PubMed ID: 32438848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia.
    Ingason A; Giegling I; Hartmann AM; Genius J; Konte B; Friedl M; ; Ripke S; Sullivan PF; St Clair D; Collier DA; O'Donovan MC; Mirnics K; Rujescu D
    Transl Psychiatry; 2015 Oct; 5(10):e656. PubMed ID: 26460480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.
    Gaskin PL; Alexander SP; Fone KC
    Psychopharmacology (Berl); 2014 Jun; 231(12):2533-45. PubMed ID: 24402141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
    Enomoto T; Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.